drugset / Trial / NCT04424394

DualStim Therapy With or Without Umbilical Cord Derived Wharton's Jelly for Erectile Dysfunction

NCT04424394 ↗

Phase 1/2 Unknown 60 enrolled BioIntegrate
RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is to determine the immediate and short-term efficacy of the methodological application of DualStim Therapy - Focused Extracorporeal Shock Wave Therapy (fESWT) and Radial Extracorporeal Shock Wave Therapy (rESWT), with and without intracavernosal administration of formulated umbilical cord derived Wharton's Jelly to improve and/or restore erectile function in patients with erectile dysfunction (ED).

Timeline

Start
2023-01-01
Primary completion
2024-12-31
Completion
2024-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Umbilical Cord-derived Wharton's Jelly Unknown — Other

Indications